Cite
APA Citation
Kumthekar, P., Gradishar, W., Lin, N., Pentsova, E., Groves, M., Jeyapalan, S., Melisko, M., Grimm, S., B. Lassman, A., & Raizer, J. (n.d.). cMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY. Neuro-oncology, 20, vi58. http://access.bl.uk/ark:/81055/vdc_100095322540.0x000015